UK Stocks-Factors to watch on March 21

March 21 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening flat on Monday, with futures FFIc1 up 0.1%.

* ASTRAZENECA: AstraZeneca AZN.L said on Monday its antibody-based cocktail to prevent and treat COVID-19 was shown to retain neutralising activity against the Omicron coronavirus variants, including BA.2 subvariant, in independent lab studies.

* SHELL: Australia's offshore petroleum watchdog has cleared the way for Shell SHEL.L to restart its Prelude floating liquefied natural gas site off northwestern Australia, after a power outage forced a shutdown in December.

* ASTRAZENECA: Bristol Myers Squibb Co BMY.N , in a lawsuit made public on Friday, said AstraZeneca's AZN.L cancer treatment Imfinzi violates patents related to its blockbuster cancer drug Opdivo.

* CVC: Europe's biggest private equity firm CVC Capital Partners is planning to shun London and take its multibillion-euro initial public offering to the Netherlands, the Financial Times reported on Saturday.

* BUDGET: British finance minister Rishi Sunak, preparing for a budget update this week, said on Sunday he would help where he could with a cost-of-living squeeze but warned that the Ukraine crisis and sanctions on Russia would add to the economy's problems.

* UK HOUSES: Asking prices for British houses have recorded their sharpest monthly jump for the time of year since March 2004, despite a growing squeeze on households' disposable income from higher energy bills and rising interest rates.

* FTSE 100: British stocks ended near session highs on Friday and the blue-chip index clocked its best weekly performance in over a year as investors digested negotiations over the Ukraine-Russia conflict and a dovish outlook from the Bank of England this week.

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

Reporting by Aby Jose Koilparambil and Sinchita Mitra in Bengaluru

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。


本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。